Mitchell T. Wallin

Mitchell Wallin practices at University of Maryland Medical Center in Baltimore, Maryland, part of University of Maryland Medical System.

Mitchell Wallin's NPI, 1154351575, was assigned on July 3, 2006. Mitchell Wallin graduated from University of Minnesota Medical School in 1990. Mitchell Wallin holds District of Columbia license MD036067.

Mitchell Wallin's primary practice is University of Maryland Medical Center, at 22 South Greene Street, Baltimore, MD 21201 in Baltimore City. The practice phone is (410) 328-8667.

Mitchell Wallin's primary practice is University of Maryland Medical Center in Baltimore, Maryland, part of University of Maryland Medical System. The medical group on file is University of Maryland Neurology Associates, P.A.

Dmand AI tracks the electronic health record (EHR) system at each site where Mitchell Wallin practices. Vendor and product names are available with a free account.

Neurology is Mitchell Wallin's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Mitchell Wallin is licensed in District of Columbia.

CMS data shows 26 Medicare services from Mitchell Wallin across 1 procedure code in 2022, all of them office visits, for 15 Medicare patients. Medicare paid $2,865 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 15 Medicare patients who saw Mitchell Wallin in 2024. The largest group is 85 and over, with 0 patients. Their average risk score is 1.03, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Mitchell Wallin's median patient age at 54, with 61% women.

In 2024, Mitchell Wallin wrote 121 Medicare Part D claims for 19 patients. 52% of them were for generic drugs. CMS names the drug for 76 of them, across 5 drugs with 11 or more claims each, at $396,808 in total drug cost. In 2023, CMS named 77 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Mitchell Wallin for performance year 2024, reported as part of a group. Mitchell Wallin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Mitchell Wallin as offering telehealth.

CMS Open Payments shows 4 general payments to Mitchell Wallin from 4 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 94% of the total. Amgen Inc. paid the most, $105.

Mitchell Wallin graduated from University of Minnesota Medical School in 1990.